Target intelligence / Profile preview

Zinc finger protein 212 (ZNF212)

Target
ZNF212
Molecular classification
Transcription factor, C2H2-type zinc finger protein, KRAB domain-containing protein
01

Overview

Zinc finger protein 212 (ZNF212) is a member of the C2H2-type zinc finger protein family, which primarily functions as a transcription factor and is involved in the regulation of gene expression[10][3][9]. ZNF212 contains three functional domains: a DUF3669 domain (function unknown), a KRAB domain (typically involved in transcriptional repression), and classical C2H2 zinc finger domains (bind DNA)[1]. ZNF212 has been shown to promote genomic integrity by acting directly in DNA repair pathways—specifically, by interacting with TRAIP and NEIL3, participating in the DNA damage response, homologous recombination, and interstrand crosslink repair[2][8]. Loss of ZNF212 results in Purkinje cell death, suggesting a critical role in neural cell survival[1]. ZNF212 may function upstream of certain repair pathways, including NEIL3 and Fanconi anemia pathways[8]. There are currently no direct reports of pharmacological modulators or drugs targeting ZNF212, nor established uses as a biomarker or therapeutic target in disease.

Other names
ZNF212ZNFC150C2H2-150Zinc finger protein C2H2-150ZNF182
02

Biological functions

Transcriptional regulationDNA damage responseHomologous recombination repairDNA interstrand crosslink repair
03

Disease associations

Potential role in neurodegeneration (Purkinje cell death)Implicated in genomic stability (role in DNA repair pathways)

Beyond the preview

Go deeper on Zinc finger protein 212 (ZNF212).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 212 (ZNF212).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call